Ecke Laurel E, Elmer Greg I, Suto Nobuyoshi
Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, NIH/DHHS, Baltimore, Maryland, USA.
Neuroreport. 2012 Mar 28;23(5):325-30. doi: 10.1097/WNR.0b013e3283517628.
The rewarding properties of psychomotor stimulants are traditionally thought to be independent of norepinephrine. Recent findings, however, suggest that local noradrenergic signaling through α1 receptors in the medial prefrontal cortex and the ventral tegmental area - brain regions critically important in natural and drug rewards - is in a position to influence stimulant reward. Despite this controversy, the contribution of this targeted signaling to stimulant self-administration has not been directly assessed. We have thus examined whether pharmacological blockade of α1 receptors in the medial prefrontal cortex and ventral tegmental area alters cocaine self-administration. Rats were trained to lever-press for cocaine (1.0 mg/kg/infusion) under a fixed ratio 1 schedule of reinforcement for 10 days. After training, the rats received a bilateral microinjection of an α1 noradrenergic antagonist (terazosin: 1.0, 5.0, or 10 mM/side), a D1 dopaminergic antagonist (SCH23390: 12.3 mM/side), or saline into either the medial prefrontal cortex or ventral tegmental area immediately before a cocaine self-administration session. Although SCH23390 significantly increased cocaine self-administration when injected into either brain region, terazosin, at all doses and sites tested, failed to alter this behavior. Thus, the maintenance of cocaine self-administration appears to be under the influence of D1 dopaminergic, rather than α1 noradrenergic, signaling at these mesocortical sites.
传统观点认为,精神运动性兴奋剂的奖赏特性与去甲肾上腺素无关。然而,最近的研究结果表明,通过内侧前额叶皮质和腹侧被盖区(在自然奖赏和药物奖赏中至关重要的脑区)中的α1受体进行的局部去甲肾上腺素能信号传导,有可能影响兴奋剂奖赏。尽管存在这一争议,但这种靶向信号传导对兴奋剂自我给药的作用尚未得到直接评估。因此,我们研究了内侧前额叶皮质和腹侧被盖区中α1受体的药理学阻断是否会改变可卡因自我给药行为。大鼠在固定比率1强化程序下接受训练,以杠杆按压方式获取可卡因(1.0毫克/千克/注射),持续10天。训练后,在每次可卡因自我给药前,大鼠在内侧前额叶皮质或腹侧被盖区接受双侧微量注射α1去甲肾上腺素能拮抗剂(特拉唑嗪:1.0、5.0或10毫摩尔/侧)、D1多巴胺能拮抗剂(SCH23390:12.3毫摩尔/侧)或生理盐水。尽管将SCH23390注射到任一脑区时均显著增加了可卡因自我给药量,但在所有测试剂量和部位,特拉唑嗪均未改变这一行为。因此,在这些中皮质位点,可卡因自我给药的维持似乎受D1多巴胺能信号而非α1去甲肾上腺素能信号的影响。